Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05026398Phase 4Completed
Phase 4, randomised, double-blind trial comparing Fenfluramine with Placebo (2 arms). Primary endpoints: Change in Go/No-Go Task performance at Day 7, Change in Auditory Verbal Learning Task at Day 7 and 1 more. Started Apr 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05026398.